Co-diagnostics, inc. completes principal design of test for monkeypox virus

Salt lake city , may 26, 2022 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed the principal design work of a pcr test for the monkeypox virus currently exhibiting a multi-country outbreak. according to the world health organization (who), monkeypox is a virus originally transmitted to humans from animals, and then transmitted from one person to another by close contact with lesions, body fluids, respiratory droplets and contaminated materials such as bedding.
CODX Ratings Summary
CODX Quant Ranking